Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D05URO
|
|||
Former ID |
DIB013639
|
|||
Drug Name |
Quinvaxem
|
|||
Synonyms |
DTPw-HepB-Hib; DTP-HBV-Hib vaccine, Berna/Chiron; DTP-HBV-Hib vaccine, Berna/Novartis; DTP-HBV-Hib vaccine, Crucell/Chiron; DTP-HBV-Hib vaccine, Crucell/Novartis; DTPw-HBV-Hib vaccine, Berna/Chiron; DTPw-HBV-Hib vaccine, Berna/Novartis; DTPw-HBV-Hib vaccine, Crucell/Chiron; DTPw-HBV-Hib vaccine, Crucell/Novartis; DTwP-Hep B-Hib vaccine, Crucell/Novartis; Diphtheria/tetanus/pertussis/Haemophilus influenzae type B, hepatitis B pentavalent vaccine, Crucell/Novartis
Click to Show/Hide
|
|||
Indication | Hepatitis B virus infection [ICD-11: 1E51.0; ICD-10: B18.1] | Approved | [1], [2] | |
Company |
Berna Biotech AG
|
References | Top | |||
---|---|---|---|---|
REF 1 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | |||
REF 2 | ClinicalTrials.gov (NCT01357720) Study to Assess if Quinvaxem Can be Interchanged With Other Pentavalent Vaccines During Standard Childhood Vaccination. U.S. National Institutes of Health. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.